Klümpen HJ - Search Results

1

A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer.

Kordes S, Richel DJ, Klümpen HJ, Weterman MJ, Stevens AJ, Wilmink JW. Kordes S, et al. Among authors: klumpen hj. Invest New Drugs. 2013 Feb;31(1):85-91. doi: 10.1007/s10637-012-9802-1. Epub 2012 Feb 25. Invest New Drugs. 2013. PMID: 22367239 Free PMC article. Clinical Trial.

2

Long-term efficacy of metal versus plastic stents in inoperable perihilar cholangiocarcinoma; a multicenter retrospective propensity score matched comparison.

Fritzsche JA, de Jong DM, Borremans JJMM, Bruno MJ, Van Delden OM, Erdmann JI, Fockens P, de Gooyer PGM, Groot Koerkamp B, Klümpen HJ, Moelker A, Montazeri NSM, Nooijen LE, Ponsioen CY, Van Wanrooij RLJ, van Driel LMJW, Voermans RP. Fritzsche JA, et al. Among authors: klumpen hj. HPB (Oxford). 2023 Jul;25(7):798-806. doi: 10.1016/j.hpb.2023.03.011. Epub 2023 Mar 23. HPB (Oxford). 2023. PMID: 37059650 Free article.

3

National consensus on a new resectability classification for perihilar cholangiocarcinoma - A modified Delphi method.

Nooijen LE, de Boer MT, Braat AE, Dewulf M, den Dulk M, Hagendoorn J, Hoogwater FJH, Lam HD, Molenaar Q, Neumann U, Porte RJ, Swijnenburg RJ, Zonderhuis B, Kazemier G, Klümpen HJ, van Gulik T, Groot Koerkamp B, Erdmann JI. Nooijen LE, et al. Among authors: klumpen hj. Eur J Surg Oncol. 2023 Oct 11:107117. doi: 10.1016/j.ejso.2023.107117. Online ahead of print. Eur J Surg Oncol. 2023. PMID: 37880001 Free article.

4

Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database.

Rijken A, Bakkers C, Klümpen HJ, van der Geest LG, de Vos-Geelen J, van Erning FN, de Hingh IHJT. Rijken A, et al. Among authors: klumpen hj. Eur J Surg Oncol. 2023 Aug;49(8):1436-1443. doi: 10.1016/j.ejso.2023.03.004. Epub 2023 Mar 5. Eur J Surg Oncol. 2023. PMID: 36898900

5

Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives.

Ten Haaft BH, Pedregal M, Prato J, Klümpen HJ, Moreno V, Lamarca A. Ten Haaft BH, et al. Among authors: klumpen hj. Eur J Cancer. 2024 Mar;199:113564. doi: 10.1016/j.ejca.2024.113564. Epub 2024 Jan 20. Eur J Cancer. 2024. PMID: 38266541 Free article. Review.

6

Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study.

Boyd LNC, Nooijen LE, Ali M, Puik JR, Moustaquim J, Fraga Rodrigues SM, Broos R, Belkouz A, Meijer LL, Le Large TYS, Erdmann JI, Hooijer GKJ, Heger M, Van Laarhoven HWM, Roos E, Kazemier G, Giovannetti E, Verheij J, Klümpen HJ. Boyd LNC, et al. Among authors: klumpen hj. Front Pharmacol. 2023 Oct 18;14:1274692. doi: 10.3389/fphar.2023.1274692. eCollection 2023. Front Pharmacol. 2023. PMID: 37920204 Free PMC article.

7

Increased dihydropyrimidine dehydrogenase activity associated with mild toxicity in patients treated with 5-fluorouracil and leucovorin.

van Kuilenburg AB, Klumpen HJ, Westermann AM, Zoetekouw L, Van Lenthe H, Bakker PJ, Richel DJ, Guchelaar HJ. van Kuilenburg AB, et al. Among authors: klumpen hj. Eur J Cancer. 2007 Jan;43(2):459-65. doi: 10.1016/j.ejca.2006.09.017. Epub 2006 Nov 13. Eur J Cancer. 2007. PMID: 17097873

8

Altered dihydropyrimidine dehydrogenase activity associated with mild toxicity in patients treated with 5-fluorouracil containing chemotherapy.

van Kuilenburg AB, Klumpen HJ, Westermann AM, Zoetekouw L, Bakker PJ, Guchelaar HJ, Richel DJ. van Kuilenburg AB, et al. Among authors: klumpen hj. Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):726-32. doi: 10.1080/15257770802145454. Nucleosides Nucleotides Nucleic Acids. 2008. PMID: 18600532

9

Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies.

Deenen MJ, Klümpen HJ, Richel DJ, Sparidans RW, Weterman MJ, Beijnen JH, Schellens JH, Wilmink JW. Deenen MJ, et al. Among authors: klumpen hj. Invest New Drugs. 2012 Aug;30(4):1557-65. doi: 10.1007/s10637-011-9723-4. Epub 2011 Aug 2. Invest New Drugs. 2012. PMID: 21809026 Free PMC article. Clinical Trial.

10

Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer.

Kordes S, Klümpen HJ, Weterman MJ, Schellens JH, Richel DJ, Wilmink JW. Kordes S, et al. Among authors: klumpen hj. Cancer Chemother Pharmacol. 2015 Jun;75(6):1135-41. doi: 10.1007/s00280-015-2730-y. Epub 2015 Mar 31. Cancer Chemother Pharmacol. 2015. PMID: 25822310 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters